The Price May Not Be Right: The Value of Comparison Shopping for Prescription Drugs

被引:0
|
作者
Arora, Sanjay [1 ]
Sood, Neeraj [2 ]
Terp, Sophie [1 ]
Joyce, Geoffrey [3 ]
机构
[1] Univ Southern Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Keck Sch Med, Los Angeles, CA 90089 USA
[2] Univ Southern Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Sol Price Sch Publ Policy, Los Angeles, CA 90089 USA
[3] Univ Southern Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Sch Pharm, Los Angeles, CA 90089 USA
来源
AMERICAN JOURNAL OF MANAGED CARE | 2017年 / 23卷 / 07期
关键词
HEALTH; NONADHERENCE;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
OBJECTIVES: To measure variations in drug prices across and within zip codes that may reveal simple strategies to improve patients' access to prescribed medications. STUDY DESIGN: We compared drug prices at different types of pharmacies across and within local markets. In-store prices were compared with a Web-based service providing discount coupons for prescription medications. Prices were collected for 2 generic antibiotics because most patients have limited experience with them and are less likely to know the price ranges for them. METHODS: Drug prices were obtained via telephone from 528 pharmacies in Los Angeles (LA) County, California, from July to August 2014. Online prices were collected from GoodRx, a popular Web-based service that aggregates available discounts and directly negotiates with retail outlets. RESULTS: Drug prices found at independent pharmacies and by using discount coupons available online were lower on average than at grocery, big-box, or chain drug stores for 2 widely prescribed antibiotics. The lowest-price prescription was offered at a grocery, big-box, or chain drug store in 6% of zip codes within the LA County area. Drug prices varied dramatically within a zip code, however, and were less expensive in lower-income areas. The average price difference within a zip code was $52 for levofloxacin and $17 for azithromycin. CONCLUSIONS: Price shopping for medications within a small geographic area can yield considerable cost savings for the uninsured and consumers in high-deductible health plans with high negotiated prices. Clinicians and patient advocates have an incentive to convey this information to patients to improve adherence to prescribed medicines and lower the financial burden of purchasing prescription drugs.
引用
收藏
页码:410 / 415
页数:6
相关论文
共 50 条
  • [21] Factors influencing the prescription of drugs of different price levels
    Semark, Birgitta
    Engstrom, Sven
    Brudin, Lars
    Tagerud, Sven
    Fredlund, Kerstin
    Borgquist, Lars
    Petersson, Goran
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (03) : 286 - 293
  • [22] THE SLOVAK EXPERIENCE IN THE INTERNATIONAL PRICE BENCHMARKING FOR PRESCRIPTION DRUGS
    Filko, M.
    Szilagyiova, P.
    VALUE IN HEALTH, 2009, 12 (07) : A229 - A230
  • [23] The price of progress: Prescription drugs in the health care market
    Kleinke, JD
    HEALTH AFFAIRS, 2001, 20 (05) : 43 - 60
  • [24] POPULATION CHARACTERISTICS AND PRICE DISPERSION IN THE MARKET FOR PRESCRIPTION DRUGS
    Ohler, Adrienne
    Smith, Vincent
    CONTEMPORARY ECONOMIC POLICY, 2013, 31 (03) : 486 - 502
  • [25] The Price of Progress: Understanding Innovation and Affordability of Prescription Drugs
    Lo Sasso, Anthony T.
    Roebuck, M. Christopher
    AMERICAN JOURNAL OF MANAGED CARE, 2024, 30 (10): : 463 - 464
  • [26] Prescription Drugs-List Price, Net Price, and the Rebate Caught in the Middle
    Dusetzina, Stacie B.
    Bach, Peter B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (16): : 1563 - 1564
  • [27] Price, value, and the cost of cancer drugs
    Fojo, Tito
    Lo, Andrew W.
    LANCET ONCOLOGY, 2016, 17 (01): : 3 - 5
  • [28] Why this price may be right after all
    Serwer, A
    FORTUNE, 2001, 143 (07) : 177 - 178
  • [29] Drugs for chronic diseases: getting the price right
    不详
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (12): : 959 - 959
  • [30] PRICE INCREASES OF PRESCRIPTION DRUGS IN SWEDEN - IN WHICH CASES ARE THEY APPROVED?
    Engstedt, R.
    Butepage, G.
    Olsson, K.
    VALUE IN HEALTH, 2022, 25 (12) : S309 - S309